Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anna Lyngsø Bliampti1, Jakob Benedict Seidelin2, Johan Burisch3,4

  • 1Det Sundhedsvidenskabelige Fakultet, Københavns Universitet.

Ugeskrift for Laeger
|May 5, 2024
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk and outcome of interstitial lung disease in inflammatory bowel disease: evidence from a Danish nationwide population-based cohort study.

Journal of Crohn's & colitis·2026
Same author

Medical and surgical therapies for patients with inflammatory bowel diseases and prior or coexisting cancer: a Danish nationwide cohort study.

Journal of Crohn's & colitis·2026
Same author

Potential of Clinical Care-Collected Gut Biopsies for Advancing Personalised Medicine in Inflammatory Bowel Disease.

United European gastroenterology journal·2026
Same author

Consensus on Irritable Bowel Syndrome-Like Symptoms in Inflammatory Bowel Disease: A Step Toward Advancing Patient-Centered Care.

Gastroenterology·2026
Same author

Inflammatory bowel disease phenotypes in diverse populations: a global comparative analysis.

Journal of Crohn's & colitis·2026
Same author

Reinduction or Redirection? Lessons From the REScUE Trial on Ustekinumab Intensification in Crohn's Disease.

Gastroenterology·2026

New inflammatory bowel disease treatments show effectiveness but carry risks like infections and low blood cell counts. Collaboration across medical specialties is crucial for managing these side effects and improving patient care.

Area of Science:

  • Gastroenterology and Immunology
  • Pharmacology and Therapeutics

Background:

  • Ulcerative colitis and Crohn's disease are chronic inflammatory bowel diseases.
  • Recent advancements include novel therapies targeting specific inflammatory pathways.

Purpose of the Study:

  • To review the efficacy and safety profiles of new treatments for inflammatory bowel diseases.
  • To highlight the necessity of multidisciplinary collaboration for managing treatment-related adverse events.

Main Methods:

  • Review of pivotal phase 3 clinical trials.
  • Analysis of reported efficacy and side effect data for novel therapeutics.

Main Results:

  • Interleukin-23, sphingosine-1-phosphate, and Janus kinase inhibitors demonstrate significant effectiveness.

Related Experiment Videos

  • Identified adverse events include herpes zoster, lymphopenia, and bradycardia.

    • Conclusions:

    • Novel therapies offer improved outcomes for inflammatory bowel diseases.
    • Proactive management of serious side effects through interdisciplinary collaboration is essential for patient safety and optimal care.